SEC Form 3 · accession 0001123292-18-000918
VACCINEX, INC. · VCNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond E. Watkins
Officer — SVP & Chief Operating Officer
Period of report
Aug 9, 2018
Accepted (ET)
Aug 9, 2018 · 6:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001205922
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 7,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $7.10 | holding | — | — | — | — | Dec 22, 2025 | Common Stock | 28,169 | — | D |
| Stock option (right to buy)F1 | $7.10 | holding | — | — | — | — | Dec 22, 2025 | Common Stock | 8,635 | — | D |
| Stock option (right to buy)F2 | $7.10 | holding | — | — | — | — | Dec 23, 2025 | Common Stock | 4,617 | — | D |
Explanation of responses
- F1Exercisable in full as of the date of this report.
- F2This option has vested with respect to 2,770 shares and the remainder vests in two equal annual installments beginning on December 23, 2018.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney